Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 mai 2026 05h11 HE | Source: Research and Markets

Next Generation Immune Checkpoint Inhibitors Market Report 2026-2035: Pipeline Features ~475 Therapy Programs, Emphasizing on Enhanced Pathway Modulation to Deliver Sustained Therapeutics in Oncology

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Immune Checkpoint Inhibitors Market (2nd Edition), by Target Immune Checkpoint, Target Disease Indication, Type of Molecule,...
15 mai 2026 07h39 HE | Source: Research and Markets

Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026" report has been...
20 avr. 2026 12h22 HE | Source: Research and Markets

Immune Checkpoint Inhibitors Market Report 2026-2030 with Detailed Company Profiles, Grant Analyses, Partnership Evaluations and More

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market: Industry Trends and Global Forecasts, till 2030" has been added to ResearchAndMarkets.com's offering. The...
13 avr. 2026 05h11 HE | Source: Research and Markets

Oncolytic Virus Market Competitive Landscape Report 2026: Detailed Insights Into 100+ Companies and 110 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Oncolytic Virus - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering.This comprehensive report offers detailed insights...
30 mars 2026 05h42 HE | Source: Research and Markets

Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Paranasal Sinus Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The paranasal sinus cancer market has shown...
18 févr. 2026 11h00 HE | Source: Research and Markets

CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "CTLA-4 Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive overview...
18 févr. 2026 10h49 HE | Source: Research and Markets

Checkpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers extensive insights...
18 févr. 2026 10h45 HE | Source: Research and Markets

PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 200+ Drugs from Over 180 Companies by Company, Product Type, Stage, Route of Administration, and Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers exhaustive...
23 janv. 2026 10h02 HE | Source: Research and Markets

CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "CD137 Targeted Therapy Market Opportunity, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insight 2026" report has been...
06 janv. 2026 09h13 HE | Source: Research and Markets

TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Report 2026-2030: Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnology Advance Deep Oncology Pipelines

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering. ...

Page suivante